data_2o22_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2o22 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.826 0.346 . . . . 11.619999999999999 111.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.15 73.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 7.3799999999999999 111.115 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 48.66 -168.32 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.668 -0.777 . . . . 5.2800000000000002 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 31.28 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 8.25 110.909 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -102.0 -49.84 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 4.0999999999999996 110.975 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.05 35.0 4.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.76 . . . . 2.79 112.435 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.434 ' CB ' ' CE3' ' A' ' 192' ' ' TRP . 19.0 p90 -50.49 141.13 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 2.3599999999999999 110.992 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.29 116.25 7.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 1.9099999999999999 110.762 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -48.23 -36.11 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 2.29 110.467 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' CG2' ' A' ' 175' ' ' THR . 0.0 OUTLIER -64.29 -43.27 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 3.73 111.617 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -33.92 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.605 -0.271 . . . . 2.4399999999999999 111.264 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.412 ' HB ' ' CH2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -65.35 -43.19 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.447 -0.342 . . . . 1.46 111.253 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG2' ' A' ' 12' ' ' ILE . 65.2 t -73.79 -33.91 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 1.1299999999999999 110.346 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -61.62 -47.32 85.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.982 -0.554 . . . . 1.3300000000000001 110.552 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -67.16 -45.46 76.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 2.4900000000000002 110.925 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.92 -56.29 23.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 2.0800000000000001 110.895 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 16' ' ' TYR . 7.8 mm -59.34 -36.98 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 1.2 111.155 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' CD2' ' CZ3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -54.11 -55.82 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 1.01 110.779 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -37.01 69.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.93999999999999995 110.8 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -60.65 -40.11 90.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 2.4500000000000002 110.731 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.23 -43.85 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 1.3700000000000001 110.877 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.76 -31.29 37.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 1.8400000000000001 110.791 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -51.73 -34.47 39.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 2.7999999999999998 110.817 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -94.08 -24.13 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 3.3700000000000001 111.251 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.16 19.29 24.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.733 . . . . 0.98999999999999999 112.484 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -88.89 98.43 11.73 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.862 0.363 . . . . 2.4199999999999999 110.737 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.94 91.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 2.5800000000000001 111.102 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.493 ' CZ3' ' CD2' ' A' ' 18' ' ' HIS . 8.9 t90 -71.85 124.37 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.84999999999999998 110.536 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.16 59.21 4.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 2.8199999999999998 110.987 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . . . -69.75 -55.19 10.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 1.49 110.949 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.79 69.45 3.09 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.801 -0.714 . . . . 3.27 112.522 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.92 -30.63 10.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 6.3899999999999997 110.93 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -80.59 72.69 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 7.25 110.984 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.68 57.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 6.5800000000000001 110.944 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -110.57 33.62 4.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 7.9100000000000001 111.108 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 47.48 83.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.428 -0.351 . . . . 9.2599999999999998 110.939 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -101.53 91.22 4.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 9.0600000000000005 110.893 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.98 57.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 9.4900000000000002 110.837 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 m -50.38 -78.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 7.5 110.915 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.22 32.22 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 9.0999999999999996 110.96 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 68.51 150.9 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 6.8099999999999996 111.122 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 -25.39 22.15 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 6.4500000000000002 112.411 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.89 116.23 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.046 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.24 52.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.824 -0.703 . . . . 3.8700000000000001 112.371 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 p -47.48 -29.55 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 4.1500000000000004 111.025 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -53.54 -72.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 3.5099999999999998 111.132 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -5.11 40.29 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 1.8600000000000001 112.033 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.23 -46.11 74.78 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.798 0.332 . . . . 2.2799999999999998 110.997 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.94 -32.24 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 2.1000000000000001 111.147 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.47 -35.46 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 1.1899999999999999 111.268 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -60.08 -49.49 77.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.422 -0.354 . . . . 1.9199999999999999 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.9 mt -59.54 -38.63 81.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 2.71 110.937 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 195' ' ' PHE . 2.3 m -66.97 -51.26 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 1.6100000000000001 111.367 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 HD21 ' CE2' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -63.38 -49.62 73.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 1.27 111.328 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -44.46 94.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.45 -0.341 . . . . 3.7400000000000002 111.363 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -73.26 -45.98 52.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.567 -0.288 . . . . 2.73 111.516 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.26 72.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 1.45 110.662 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.87 15.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 1.24 112.394 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -32.9 73.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 2.1800000000000002 110.725 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.76 -45.63 91.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 1.8899999999999999 110.747 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.459 ' CD2' ' N ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -59.61 -53.28 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 2.1299999999999999 111.385 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.459 ' N ' ' CD2' ' A' ' 101' ' ' PHE . 1.3 p -56.32 -34.85 66.93 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.398 -0.819 . . . . 1.6499999999999999 110.715 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -64.73 -30.85 71.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 3.8900000000000001 110.958 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -78.15 -14.0 59.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 4.25 112.379 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.609 ' CE2' ' H10' ' A' 1000 ' ' LIU . 24.9 m-85 -120.53 89.87 3.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.424 0.631 . . . . 3.3599999999999999 111.12 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -46.3 72.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.955 -1.02 . . . . 5.0899999999999999 112.754 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -118.38 101.59 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.502 0.556 . . . . 5.2199999999999998 112.502 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' OD2' ' CD2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -174.72 -70.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 2.6200000000000001 111.176 178.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 110' ' ' ALA . 18.2 p90 -75.27 -42.23 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.902 0.334 . . . . 2.1200000000000001 111.902 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 109' ' ' PHE . . . -69.79 -48.81 57.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 1.27 111.301 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -41.48 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 2.54 111.123 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 28.6 mtm -70.11 -27.53 64.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 1.45 111.387 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -51.2 -35.12 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.505 -0.316 . . . . 1.95 111.362 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 m -53.81 -33.27 55.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 2.3799999999999999 111.092 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -74.08 -33.47 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.524 . . . . 2.8700000000000001 111.422 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -34.0 47.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 111.51 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.14 172.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.02 -0.272 . . . . 4.3600000000000003 110.289 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.91 127.68 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 2.75 111.087 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 177.71 134.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 2.0499999999999998 109.739 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -25.2 15.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 1.9199999999999999 113.226 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.15 -55.21 5.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 4.6900000000000004 111.705 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -25.88 56.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.613 0.598 . . . . 2.8599999999999999 112.613 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 126' ' ' ARG . . . -46.93 -50.75 18.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 1.3799999999999999 111.88 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -60.68 -48.72 80.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.339 . . . . 3.0800000000000001 110.964 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.61 -32.39 81.36 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.785 -0.722 . . . . 0.48999999999999999 112.57 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 123' ' ' ALA . 4.5 ptt85 -76.02 -23.85 55.22 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.448 0.536 . . . . 3.48 112.448 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -65.85 -53.56 38.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 1.96 110.968 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' N ' ' CD2' ' A' ' 127' ' ' PHE . . . -50.33 -50.91 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.416 . . . . 1.04 111.548 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 -29.86 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 1.0600000000000001 112.125 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 131' ' ' VAL . 0.7 OUTLIER -78.51 -42.64 26.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.413 -0.515 . . . . 1.1899999999999999 112.0 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.401 ' N ' ' CG2' ' A' ' 130' ' ' VAL . 2.7 p -73.89 -32.58 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.1100000000000001 110.224 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -38.69 77.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 2.0299999999999998 110.944 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.53 -27.87 58.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 2.29 111.126 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -46.72 88.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.02 0.438 . . . . 1.3600000000000001 110.454 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 181' ' ' HIS . 1.1 t80 -112.8 86.8 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.817 -1.549 . . . . 1.8100000000000001 106.817 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.54 -34.7 9.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.922 0.391 . . . . 4.4500000000000002 110.579 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.66 -61.58 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 2.8399999999999999 110.584 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -149.49 160.21 28.37 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.879 -0.6 . . . . 1.3500000000000001 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.04 163.09 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.173 0.511 . . . . 1.0600000000000001 112.342 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -168.39 163.28 12.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.544 -0.753 . . . . 2.6600000000000001 110.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -50.88 -47.08 60.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.40000000000000002 110.398 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.595 ' HA3' HN17 ' A' 1000 ' ' LIU . . . -61.81 -33.63 85.97 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.934 -0.575 . . . . 0.40000000000000002 112.782 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -45.13 29.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.731 0.3 . . . . 2.5499999999999998 110.603 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.1 mt -52.44 -55.06 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.086 -0.709 . . . . 1.0700000000000001 109.086 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -44.48 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.524 -0.762 . . . . 1.22 111.549 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 101' ' ' PHE . . . -56.01 -52.96 62.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.479 -0.328 . . . . 1.0800000000000001 111.579 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -59.01 -44.34 91.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 2.1899999999999999 110.408 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -51.27 -49.93 60.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.514 . . . . 2.0499999999999998 110.468 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.97 -39.69 95.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 2.21 110.763 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -49.63 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 1.8700000000000001 110.856 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.08 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.671 -0.776 . . . . 0.46000000000000002 112.339 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.92 -43.09 99.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.687 -0.768 . . . . 0.31 112.224 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.26 -37.34 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 1.55 110.825 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.37 -47.66 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 1.4299999999999999 111.252 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -37.12 63.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 1.3300000000000001 110.489 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.5 t -76.52 -34.24 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 1.3600000000000001 110.813 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -49.9 -46.64 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.905 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -41.31 81.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.8799999999999999 110.62 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 156' ' ' VAL . 1.3 m -65.03 -30.05 49.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.511 -0.313 . . . . 1.1799999999999999 111.323 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.6 -46.19 66.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 1.96 110.957 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -87.96 -74.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 3.6499999999999999 110.68 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -178.48 61.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 2.3399999999999999 110.827 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.06 44.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.8999999999999999 111.187 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.461 ' N ' ' CD ' ' A' ' 165' ' ' PRO . 0.0 OUTLIER -50.49 -49.44 77.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 1.8999999999999999 110.751 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 164' ' ' SER . 80.0 Cg_exo -47.66 -32.57 16.66 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 0.96999999999999997 112.405 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.6 tp -55.81 -26.62 47.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 2.27 111.399 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.7 m -53.6 -31.28 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 1.1200000000000001 110.994 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -46.74 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.72 110.359 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -59.39 -37.31 77.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.836 -0.62 . . . . 1.96 110.681 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -53.9 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 1.1699999999999999 110.984 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.78 59.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 1.1599999999999999 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.12 59.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 1.28 110.987 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.426 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . 16.3 m0 -64.61 -37.15 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.40999999999999998 110.996 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.417 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -62.02 -37.78 86.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 1.6699999999999999 110.732 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 10' ' ' ARG . 71.1 p -73.46 -31.63 63.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 1.0700000000000001 111.075 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 180' ' ' ARG . 5.3 tp10 -68.5 -53.52 22.72 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.529 -0.305 . . . . 1.6200000000000001 110.49 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.84 -46.33 68.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 2.1800000000000002 111.187 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 9.8 tt -50.65 -52.82 36.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.191 0.52 . . . . 1.4299999999999999 109.733 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -29.95 61.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.895 0.331 . . . . 2.46 111.895 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -65.46 -24.76 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.372 -0.531 . . . . 3.54 111.051 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.526 ' CD2' ' CD2' ' A' ' 135' ' ' PHE . 7.5 t60 -127.97 -55.08 1.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.86 0.689 . . . . 1.1699999999999999 112.86 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 181' ' ' HIS . 2.9 mp -62.54 -54.35 41.1 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.999 0.74 . . . . 1.3 112.999 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.411 ' HA ' HG12 ' A' ' 186' ' ' ILE . 4.1 t60 -41.67 -39.03 1.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.826 0.346 . . . . 2.2999999999999998 111.613 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -44.27 76.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.516 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -70.85 -37.71 73.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.051 -0.522 . . . . 0.68000000000000005 110.696 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.452 ' CG1' ' N ' ' A' ' 187' ' ' GLN . 1.2 pt -74.03 -49.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.449 -0.341 . . . . 1.23 111.858 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.452 ' N ' ' CG1' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -63.26 -47.49 82.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 3.3999999999999999 110.535 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.12 -30.4 68.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 2.21 110.841 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -111.1 52.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 2.6000000000000001 111.065 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.4 -89.34 0.82 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 1.79 112.592 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.41 -162.19 30.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.862 -0.685 . . . . 0.91000000000000003 112.356 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.434 ' CE3' ' CB ' ' A' ' 7' ' ' TYR . 24.9 m0 -59.11 -37.56 77.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.70999999999999996 110.911 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -69.05 -25.88 64.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 2.0800000000000001 111.508 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.55 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 1.0800000000000001 110.951 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.42 ' CZ ' HG22 ' A' ' 93' ' ' THR . 2.1 t80 -69.66 -41.61 75.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 2.0600000000000001 111.777 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.15 -32.65 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.635 -0.426 . . . . 1.6399999999999999 110.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -68.64 -41.04 79.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.005 0.431 . . . . 2.0600000000000001 109.845 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.06 -44.52 72.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.851 -0.613 . . . . 1.9399999999999999 110.154 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -107.07 53.88 0.68 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.872 0.844 . . . . 2.3500000000000001 110.873 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.48 110.32 3.13 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 113.724 -1.58 . . . . 1.8999999999999999 110.395 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.22 158.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.281 1.988 . . . . 3.1000000000000001 112.725 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 60.5 p -47.14 98.81 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.066 -0.515 . . . . 5.54 110.205 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 83.27 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.523 -0.762 . . . . 6.6699999999999999 112.065 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 8.2599999999999998 110.865 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1000 ' ' LIU . . . . . 0.756 H412 ' H23' ' A' 1000 ' ' LIU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.7 t-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.826 0.346 . . . . 10.949999999999999 111.173 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 1' ' ' HIS . . . 178.15 73.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 7.25 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 48.66 -168.32 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.668 -0.777 . . . . 5.2199999999999998 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 31.28 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 7.6100000000000003 110.909 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 46' ' ' GLU . 27.7 m -102.0 -49.84 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 3.6600000000000001 110.975 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.05 35.0 4.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.76 . . . . 2.2599999999999998 112.435 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' HB2' ' CE3' ' A' ' 192' ' ' TRP . 19.0 p90 -50.49 141.13 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 1.8 110.992 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.29 116.25 7.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 1.9099999999999999 110.762 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.404 ' OD1' HD22 ' A' ' 178' ' ' LEU . 17.0 m-80 -48.23 -36.11 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 2.25 110.467 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.0 OUTLIER -64.29 -43.27 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 3.25 111.617 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -33.92 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.605 -0.271 . . . . 2.4399999999999999 111.264 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -65.35 -43.19 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.447 -0.342 . . . . 0.81000000000000005 111.253 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG22 ' HE1' ' A' ' 148' ' ' PHE . 65.2 t -73.79 -33.91 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.346 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -61.62 -47.32 85.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.982 -0.554 . . . . 1.0700000000000001 110.552 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -67.16 -45.46 76.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 2.02 110.925 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.92 -56.29 23.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.895 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.407 HG12 ' CD2' ' A' ' 16' ' ' TYR . 7.8 mm -59.34 -36.98 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.48999999999999999 111.155 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' CD2' ' CZ3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -54.11 -55.82 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.62 110.779 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -37.01 69.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.47999999999999998 110.8 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -60.65 -40.11 90.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.8400000000000001 110.731 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -77.23 -43.85 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.70999999999999996 110.877 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.76 -31.29 37.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 1.4399999999999999 110.791 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -51.73 -34.47 39.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 2.21 110.817 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -94.08 -24.13 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 2.5800000000000001 111.251 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.16 19.29 24.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.733 . . . . 0.98999999999999999 112.484 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -88.89 98.43 11.73 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.862 0.363 . . . . 1.49 110.737 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.94 91.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 2.5800000000000001 111.102 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 30' ' ' ALA . 8.9 t90 -71.85 124.37 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.84999999999999998 110.536 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.16 59.21 4.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 2.8199999999999998 110.987 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 28' ' ' TRP . . . -69.75 -55.19 10.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 1.46 110.949 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.79 69.45 3.09 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.801 -0.714 . . . . 3.27 112.522 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.92 -30.63 10.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 6.3899999999999997 110.93 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -80.59 72.69 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 7.25 110.984 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 34' ' ' VAL . 35.6 m -86.68 57.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 6.1200000000000001 110.944 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -110.57 33.62 4.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 7.9100000000000001 111.108 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 47.48 83.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.428 -0.351 . . . . 9.2599999999999998 110.939 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -101.53 91.22 4.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 8.5800000000000001 110.893 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.98 57.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 9.0299999999999994 110.837 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 40' ' ' GLU . 15.7 m -50.38 -78.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 7.1399999999999997 110.915 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 39' ' ' THR . 20.8 mt-10 -110.22 32.22 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 9.0999999999999996 110.96 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 68.51 150.9 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 6.5099999999999998 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 -25.39 22.15 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 5.9299999999999997 112.411 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.89 116.23 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.046 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.24 52.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.824 -0.703 . . . . 3.6800000000000002 112.371 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 p -47.48 -29.55 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 3.75 111.025 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 89' ' ' VAL . 7.9 mt-10 -53.54 -72.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 3.5099999999999998 111.132 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -74.31 -5.11 40.29 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 1.5900000000000001 112.033 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.23 -46.11 74.78 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.798 0.332 . . . . 2.2799999999999998 110.997 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 46' ' ' GLU . 35.7 m -56.94 -32.24 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 1.49 111.147 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG12 HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -78.47 -35.46 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.58999999999999997 111.268 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -60.08 -49.49 77.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.422 -0.354 . . . . 1.76 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.9 mt -59.54 -38.63 81.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 2.1400000000000001 110.937 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.532 HG22 ' CZ ' ' A' ' 195' ' ' PHE . 2.3 m -66.97 -51.26 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 1.0600000000000001 111.367 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -49.62 73.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.52000000000000002 111.328 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -44.46 94.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.45 -0.341 . . . . 3.3599999999999999 111.363 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -73.26 -45.98 52.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.567 -0.288 . . . . 2.3100000000000001 111.516 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.26 72.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.83999999999999997 110.662 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.665 ' HA2' HG23 ' A' ' 145' ' ' VAL . . . -49.66 -54.87 15.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 1.24 112.394 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -32.9 73.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 2.1800000000000002 110.725 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.76 -45.63 91.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 1.8899999999999999 110.747 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.459 ' CD2' ' N ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -59.61 -53.28 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 1.4099999999999999 111.385 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.459 ' N ' ' CD2' ' A' ' 101' ' ' PHE . 1.3 p -56.32 -34.85 66.93 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.398 -0.819 . . . . 1.55 110.715 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -64.73 -30.85 71.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 3.4300000000000002 110.958 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -78.15 -14.0 59.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 3.73 112.379 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.606 ' CE2' ' H10' ' A' 1000 ' ' LIU . 24.9 m-85 -120.53 89.87 3.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.424 0.631 . . . . 2.7200000000000002 111.12 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -46.3 72.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.955 -1.02 . . . . 4.4100000000000001 112.754 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -118.38 101.59 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.502 0.556 . . . . 4.6799999999999997 112.502 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -174.72 -70.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 2.6200000000000001 111.176 178.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 110' ' ' ALA . 18.2 p90 -75.27 -42.23 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.902 0.334 . . . . 1.24 111.902 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 109' ' ' PHE . . . -69.79 -48.81 57.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 0.75 111.301 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -41.48 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 2.54 111.123 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 28.6 mtm -70.11 -27.53 64.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 1.04 111.387 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -51.2 -35.12 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.505 -0.316 . . . . 1.6399999999999999 111.362 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 m -53.81 -33.27 55.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 2.1499999999999999 111.092 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -74.08 -33.47 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.524 . . . . 2.6200000000000001 111.422 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -52.51 -34.0 47.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 111.51 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.619 ' N ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER 60.14 172.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.02 -0.272 . . . . 3.6600000000000001 110.289 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 119' ' ' THR . 0.6 OUTLIER -113.91 127.68 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 2.1200000000000001 111.087 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 177.71 134.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 1.53 109.739 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -25.2 15.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 1.9199999999999999 113.226 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.15 -55.21 5.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 3.9399999999999999 111.705 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -25.88 56.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.613 0.598 . . . . 2.3700000000000001 112.613 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 119' ' ' THR . . . -46.93 -50.75 18.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.93000000000000005 111.88 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -60.68 -48.72 80.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.339 . . . . 2.5600000000000001 110.964 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.61 -32.39 81.36 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.785 -0.722 . . . . 0.45000000000000001 112.57 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.605 ' HG2' ' HA ' ' A' ' 123' ' ' ALA . 4.5 ptt85 -76.02 -23.85 55.22 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.448 0.536 . . . . 2.96 112.448 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -65.85 -53.56 38.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 1.1499999999999999 110.968 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' N ' ' CD2' ' A' ' 127' ' ' PHE . . . -50.33 -50.91 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.416 . . . . 0.37 111.548 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 -29.86 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.51000000000000001 112.125 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -78.51 -42.64 26.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.413 -0.515 . . . . 0.46999999999999997 112.0 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.401 ' N ' ' CG2' ' A' ' 130' ' ' VAL . 2.7 p -73.89 -32.58 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 0.35999999999999999 110.224 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -38.69 77.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 2.0299999999999998 110.944 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.53 -27.87 58.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 2.29 111.126 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.478 HD12 ' HG3' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -61.71 -46.72 88.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.02 0.438 . . . . 0.58999999999999997 110.454 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 181' ' ' HIS . 1.1 t80 -112.8 86.8 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.817 -1.549 . . . . 1.0700000000000001 106.817 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.54 -34.7 9.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.922 0.391 . . . . 3.6099999999999999 110.579 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.66 -61.58 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 2.8399999999999999 110.584 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -149.49 160.21 28.37 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.67000000000000004 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -96.04 163.09 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.173 0.511 . . . . 0.38 112.342 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.569 ' O ' HD12 ' A' ' 144' ' ' ILE . 1.2 m120 -168.39 163.28 12.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.788 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.918 ' O ' HG12 ' A' ' 145' ' ' VAL . 22.2 m95 -50.88 -47.08 60.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.32000000000000001 110.398 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.61 ' O ' HG13 ' A' ' 145' ' ' VAL . . . -61.81 -33.63 85.97 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.934 -0.575 . . . . 0.34000000000000002 112.782 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HG3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.9 -45.13 29.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.731 0.3 . . . . 2.0 110.603 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 140' ' ' ASN . 3.1 mt -52.44 -55.06 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.086 -0.709 . . . . 0.31 109.086 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.918 HG12 ' O ' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -51.66 -44.48 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.524 -0.762 . . . . 0.56000000000000005 111.549 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB1' ' C3 ' ' A' 1000 ' ' LIU . . . -56.01 -52.96 62.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.479 -0.328 . . . . 0.29999999999999999 111.579 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.68 ' HE1' HD12 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.01 -44.34 91.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 1.3600000000000001 110.408 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' HE1' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -51.27 -49.93 60.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.514 . . . . 1.21 110.468 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.97 -39.69 95.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 2.21 110.763 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -49.63 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 1.1599999999999999 110.856 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.08 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.671 -0.776 . . . . 0.46000000000000002 112.339 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.92 -43.09 99.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.687 -0.768 . . . . 0.28000000000000003 112.224 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.26 -37.34 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 110.825 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.37 -47.66 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 1.27 111.252 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.522 ' O ' HG12 ' A' ' 167' ' ' VAL . 0.1 OUTLIER -54.02 -37.12 63.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.92000000000000004 110.489 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 159' ' ' VAL . 1.5 t -76.52 -34.24 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.813 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -49.9 -46.64 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.905 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -41.31 81.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.62 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 164' ' ' SER . 1.3 m -65.03 -30.05 49.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.511 -0.313 . . . . 0.51000000000000001 111.323 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.6 -46.19 66.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 1.5800000000000001 110.957 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -87.96 -74.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 3.2000000000000002 110.68 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -178.48 61.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 2.3399999999999999 110.827 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.06 44.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.4199999999999999 111.187 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.892 ' HA ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -50.49 -49.44 77.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 1.5700000000000001 110.751 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 164' ' ' SER . 80.0 Cg_exo -47.66 -32.57 16.66 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 0.70999999999999996 112.405 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.6 tp -55.81 -26.62 47.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.71 111.399 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 164' ' ' SER . 22.7 m -53.6 -31.28 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.42999999999999999 110.994 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -46.74 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.72 110.359 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -59.39 -37.31 77.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.836 -0.62 . . . . 1.96 110.681 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -53.9 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 110.984 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 175' ' ' THR . . . -54.97 -30.78 59.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 0.38 110.72 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -66.84 -51.12 59.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.54000000000000004 110.987 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . 16.3 m0 -64.61 -37.15 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.37 110.996 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -62.02 -37.78 86.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 1.5900000000000001 110.732 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 10' ' ' ARG . 71.1 p -73.46 -31.63 63.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.47999999999999998 111.075 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 180' ' ' ARG . 5.3 tp10 -68.5 -53.52 22.72 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.529 -0.305 . . . . 1.6200000000000001 110.49 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.84 -46.33 68.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 1.3100000000000001 111.187 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.68 HD12 ' HE1' ' A' ' 147' ' ' PHE . 9.8 tt -50.65 -52.82 36.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 109.733 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -29.95 61.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.895 0.331 . . . . 1.8100000000000001 111.895 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -65.46 -24.76 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.372 -0.531 . . . . 3.0699999999999998 111.051 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.526 ' CD2' ' CD2' ' A' ' 135' ' ' PHE . 7.5 t60 -127.97 -55.08 1.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.86 0.689 . . . . 0.96999999999999997 112.86 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 186' ' ' ILE . 2.9 mp -62.54 -54.35 41.1 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.999 0.74 . . . . 0.71999999999999997 112.999 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.423 ' HA ' HG12 ' A' ' 186' ' ' ILE . 4.1 t60 -41.67 -39.03 1.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.826 0.346 . . . . 1.5900000000000001 111.613 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -44.27 76.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.516 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -70.85 -37.71 73.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.051 -0.522 . . . . 0.59999999999999998 110.696 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 182' ' ' LEU . 1.2 pt -74.03 -49.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.449 -0.341 . . . . 0.46999999999999997 111.858 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.452 ' N ' ' CG1' ' A' ' 186' ' ' ILE . 1.4 tm0? -63.26 -47.49 82.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 2.73 110.535 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.12 -30.4 68.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 2.21 110.841 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -111.1 52.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 2.46 111.065 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.4 -89.34 0.82 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 1.79 112.592 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.41 -162.19 30.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.862 -0.685 . . . . 0.57999999999999996 112.356 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.702 ' CD1' HD12 ' A' ' 186' ' ' ILE . 24.9 m0 -59.11 -37.56 77.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.60999999999999999 110.911 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 196' ' ' VAL . 12.3 p-10 -69.05 -25.88 64.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 2.0800000000000001 111.508 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.55 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.34000000000000002 110.951 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.532 ' CZ ' HG22 ' A' ' 93' ' ' THR . 2.1 t80 -69.66 -41.61 75.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 1.1799999999999999 111.777 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -63.15 -32.65 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.635 -0.426 . . . . 1.02 110.768 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -68.64 -41.04 79.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.005 0.431 . . . . 2.0600000000000001 109.845 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.06 -44.52 72.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.851 -0.613 . . . . 1.3100000000000001 110.154 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.639 ' CD1' H402 ' A' 1000 ' ' LIU . 47.4 m-85 -107.07 53.88 0.68 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.872 0.844 . . . . 1.76 110.873 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.48 110.32 3.13 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 113.724 -1.58 . . . . 1.8999999999999999 110.395 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.22 158.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.281 1.988 . . . . 2.8700000000000001 112.725 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 60.5 p -47.14 98.81 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.066 -0.515 . . . . 5.0899999999999999 110.205 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 83.27 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.523 -0.762 . . . . 6.1900000000000004 112.065 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 7.6299999999999999 110.865 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1000 ' ' LIU . . . . . 0.892 ' H33' HG11 ' A' ' 145' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.7 t-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.826 0.346 . . . . 10.949999999999999 111.173 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 1' ' ' HIS . . . 178.15 73.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 7.25 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 48.66 -168.32 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.668 -0.777 . . . . 5.2199999999999998 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 31.28 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 7.6100000000000003 110.909 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 46' ' ' GLU . 27.7 m -102.0 -49.84 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 3.6600000000000001 110.975 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.05 35.0 4.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.76 . . . . 2.2599999999999998 112.435 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' HB2' ' CE3' ' A' ' 192' ' ' TRP . 19.0 p90 -50.49 141.13 12.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 1.8 110.992 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.29 116.25 7.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 1.9099999999999999 110.762 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.404 ' OD1' HD22 ' A' ' 178' ' ' LEU . 17.0 m-80 -48.23 -36.11 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 2.25 110.467 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.0 OUTLIER -64.29 -43.27 95.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.7 -0.682 . . . . 3.25 111.617 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -33.92 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.605 -0.271 . . . . 2.4399999999999999 111.264 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -65.35 -43.19 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.447 -0.342 . . . . 0.81000000000000005 111.253 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG22 ' HE1' ' A' ' 148' ' ' PHE . 65.2 t -73.79 -33.91 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.346 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -61.62 -47.32 85.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.982 -0.554 . . . . 1.0700000000000001 110.552 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -67.16 -45.46 76.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 2.02 110.925 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.92 -56.29 23.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.895 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.407 HG12 ' CD2' ' A' ' 16' ' ' TYR . 7.8 mm -59.34 -36.98 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.48999999999999999 111.155 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' CD2' ' CZ3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -54.11 -55.82 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.62 110.779 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -37.01 69.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.47999999999999998 110.8 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -60.65 -40.11 90.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 1.8400000000000001 110.731 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -77.23 -43.85 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.70999999999999996 110.877 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.76 -31.29 37.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 1.4399999999999999 110.791 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -51.73 -34.47 39.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 2.21 110.817 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -94.08 -24.13 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 2.5800000000000001 111.251 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.16 19.29 24.13 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.733 . . . . 0.98999999999999999 112.484 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -88.89 98.43 11.73 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.862 0.363 . . . . 1.49 110.737 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.94 91.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 2.5800000000000001 111.102 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 30' ' ' ALA . 8.9 t90 -71.85 124.37 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.84999999999999998 110.536 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -83.16 59.21 4.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 2.8199999999999998 110.987 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 28' ' ' TRP . . . -69.75 -55.19 10.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 1.46 110.949 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.79 69.45 3.09 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.801 -0.714 . . . . 3.27 112.522 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.92 -30.63 10.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 6.3899999999999997 110.93 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -80.59 72.69 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 7.25 110.984 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 34' ' ' VAL . 35.6 m -86.68 57.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 6.1200000000000001 110.944 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -110.57 33.62 4.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 7.9100000000000001 111.108 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 47.48 83.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.428 -0.351 . . . . 9.2599999999999998 110.939 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -101.53 91.22 4.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 8.5800000000000001 110.893 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.98 57.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 9.0299999999999994 110.837 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 40' ' ' GLU . 15.7 m -50.38 -78.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 7.1399999999999997 110.915 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 39' ' ' THR . 20.8 mt-10 -110.22 32.22 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 9.0999999999999996 110.96 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 68.51 150.9 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 6.5099999999999998 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 -25.39 22.15 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 5.9299999999999997 112.411 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.89 116.23 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.046 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.24 52.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.824 -0.703 . . . . 3.6800000000000002 112.371 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 p -47.48 -29.55 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.795 0.331 . . . . 3.75 111.025 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 89' ' ' VAL . 7.9 mt-10 -53.54 -72.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 3.5099999999999998 111.132 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -74.31 -5.11 40.29 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 1.5900000000000001 112.033 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.23 -46.11 74.78 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.798 0.332 . . . . 2.2799999999999998 110.997 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 46' ' ' GLU . 35.7 m -56.94 -32.24 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 1.49 111.147 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG12 HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -78.47 -35.46 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.58999999999999997 111.268 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -60.08 -49.49 77.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.422 -0.354 . . . . 1.76 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.9 mt -59.54 -38.63 81.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 2.1400000000000001 110.937 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.532 HG22 ' CZ ' ' A' ' 195' ' ' PHE . 2.3 m -66.97 -51.26 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 1.0600000000000001 111.367 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -49.62 73.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.52000000000000002 111.328 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -44.46 94.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.45 -0.341 . . . . 3.3599999999999999 111.363 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -73.26 -45.98 52.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.567 -0.288 . . . . 2.3100000000000001 111.516 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.16 -49.26 72.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.934 0.397 . . . . 0.83999999999999997 110.662 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.665 ' HA2' HG23 ' A' ' 145' ' ' VAL . . . -49.66 -54.87 15.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 1.24 112.394 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -32.9 73.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 2.1800000000000002 110.725 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.76 -45.63 91.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 1.8899999999999999 110.747 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.459 ' CD2' ' N ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -59.61 -53.28 59.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 1.4099999999999999 111.385 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.459 ' N ' ' CD2' ' A' ' 101' ' ' PHE . 1.3 p -56.32 -34.85 66.93 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.398 -0.819 . . . . 1.55 110.715 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -64.73 -30.85 71.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 3.4300000000000002 110.958 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -78.15 -14.0 59.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 3.73 112.379 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.606 ' CE2' ' H10' ' A' 1000 ' ' LIU . 24.9 m-85 -120.53 89.87 3.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.424 0.631 . . . . 2.7200000000000002 111.12 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -46.3 72.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.955 -1.02 . . . . 4.4100000000000001 112.754 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -118.38 101.59 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.502 0.556 . . . . 4.6799999999999997 112.502 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -174.72 -70.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 2.6200000000000001 111.176 178.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 110' ' ' ALA . 18.2 p90 -75.27 -42.23 55.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.902 0.334 . . . . 1.24 111.902 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 109' ' ' PHE . . . -69.79 -48.81 57.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 0.75 111.301 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -41.48 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 2.54 111.123 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 28.6 mtm -70.11 -27.53 64.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 1.04 111.387 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -51.2 -35.12 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.505 -0.316 . . . . 1.6399999999999999 111.362 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 m -53.81 -33.27 55.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 2.1499999999999999 111.092 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -74.08 -33.47 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.524 . . . . 2.6200000000000001 111.422 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -52.51 -34.0 47.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 1.8100000000000001 111.51 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.619 ' N ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER 60.14 172.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.02 -0.272 . . . . 3.6600000000000001 110.289 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 119' ' ' THR . 0.6 OUTLIER -113.91 127.68 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 2.1200000000000001 111.087 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 177.71 134.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 1.53 109.739 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -25.2 15.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 1.9199999999999999 113.226 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.15 -55.21 5.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 3.9399999999999999 111.705 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -25.88 56.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.613 0.598 . . . . 2.3700000000000001 112.613 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 119' ' ' THR . . . -46.93 -50.75 18.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.93000000000000005 111.88 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -60.68 -48.72 80.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.339 . . . . 2.5600000000000001 110.964 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.61 -32.39 81.36 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.785 -0.722 . . . . 0.45000000000000001 112.57 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.605 ' HG2' ' HA ' ' A' ' 123' ' ' ALA . 4.5 ptt85 -76.02 -23.85 55.22 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.448 0.536 . . . . 2.96 112.448 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -65.85 -53.56 38.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 1.1499999999999999 110.968 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' N ' ' CD2' ' A' ' 127' ' ' PHE . . . -50.33 -50.91 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.416 . . . . 0.37 111.548 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 -29.86 34.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.51000000000000001 112.125 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -78.51 -42.64 26.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.413 -0.515 . . . . 0.46999999999999997 112.0 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.401 ' N ' ' CG2' ' A' ' 130' ' ' VAL . 2.7 p -73.89 -32.58 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 0.35999999999999999 110.224 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -38.69 77.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 2.0299999999999998 110.944 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.53 -27.87 58.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 2.29 111.126 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.478 HD12 ' HG3' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -61.71 -46.72 88.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.02 0.438 . . . . 0.58999999999999997 110.454 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 181' ' ' HIS . 1.1 t80 -112.8 86.8 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.817 -1.549 . . . . 1.0700000000000001 106.817 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.54 -34.7 9.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.922 0.391 . . . . 3.6099999999999999 110.579 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.66 -61.58 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 2.8399999999999999 110.584 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -149.49 160.21 28.37 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.67000000000000004 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 140' ' ' ASN . 0.4 OUTLIER -96.04 163.09 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.173 0.511 . . . . 0.38 112.342 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.569 ' O ' HD12 ' A' ' 144' ' ' ILE . 1.2 m120 -168.39 163.28 12.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.788 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.918 ' O ' HG12 ' A' ' 145' ' ' VAL . 22.2 m95 -50.88 -47.08 60.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.32000000000000001 110.398 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.61 ' O ' HG13 ' A' ' 145' ' ' VAL . . . -61.81 -33.63 85.97 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.934 -0.575 . . . . 0.34000000000000002 112.782 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HG3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.9 -45.13 29.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.731 0.3 . . . . 2.0 110.603 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 140' ' ' ASN . 3.1 mt -52.44 -55.06 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.086 -0.709 . . . . 0.31 109.086 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.918 HG12 ' O ' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -51.66 -44.48 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.524 -0.762 . . . . 0.56000000000000005 111.549 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB1' ' C3 ' ' A' 1000 ' ' LIU . . . -56.01 -52.96 62.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.479 -0.328 . . . . 0.29999999999999999 111.579 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.68 ' HE1' HD12 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.01 -44.34 91.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 1.3600000000000001 110.408 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' HE1' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -51.27 -49.93 60.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.068 -0.514 . . . . 1.21 110.468 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.97 -39.69 95.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 2.21 110.763 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -49.63 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 1.1599999999999999 110.856 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.08 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.671 -0.776 . . . . 0.46000000000000002 112.339 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.92 -43.09 99.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.687 -0.768 . . . . 0.28000000000000003 112.224 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.26 -37.34 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 110.825 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.37 -47.66 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.988 -0.551 . . . . 1.27 111.252 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.522 ' O ' HG12 ' A' ' 167' ' ' VAL . 0.1 OUTLIER -54.02 -37.12 63.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.92000000000000004 110.489 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 159' ' ' VAL . 1.5 t -76.52 -34.24 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.813 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -49.9 -46.64 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.905 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -41.31 81.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.62 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 164' ' ' SER . 1.3 m -65.03 -30.05 49.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.511 -0.313 . . . . 0.51000000000000001 111.323 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.6 -46.19 66.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 1.5800000000000001 110.957 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -87.96 -74.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 3.2000000000000002 110.68 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -178.48 61.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 2.3399999999999999 110.827 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.06 44.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.4199999999999999 111.187 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.892 ' HA ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -50.49 -49.44 77.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 1.5700000000000001 110.751 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 164' ' ' SER . 80.0 Cg_exo -47.66 -32.57 16.66 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 0.70999999999999996 112.405 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.6 tp -55.81 -26.62 47.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 1.71 111.399 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 164' ' ' SER . 22.7 m -53.6 -31.28 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.42999999999999999 110.994 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -46.74 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.72 110.359 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -59.39 -37.31 77.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.836 -0.62 . . . . 1.96 110.681 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -53.9 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 110.984 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 175' ' ' THR . . . -54.97 -30.78 59.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 0.38 110.72 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -66.84 -51.12 59.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.54000000000000004 110.987 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . 16.3 m0 -64.61 -37.15 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.37 110.996 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -62.02 -37.78 86.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 1.5900000000000001 110.732 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 10' ' ' ARG . 71.1 p -73.46 -31.63 63.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.47999999999999998 111.075 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 180' ' ' ARG . 5.3 tp10 -68.5 -53.52 22.72 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.529 -0.305 . . . . 1.6200000000000001 110.49 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.84 -46.33 68.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 1.3100000000000001 111.187 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.68 HD12 ' HE1' ' A' ' 147' ' ' PHE . 9.8 tt -50.65 -52.82 36.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 109.733 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -29.95 61.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.895 0.331 . . . . 1.8100000000000001 111.895 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -65.46 -24.76 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.372 -0.531 . . . . 3.0699999999999998 111.051 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.526 ' CD2' ' CD2' ' A' ' 135' ' ' PHE . 7.5 t60 -127.97 -55.08 1.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.86 0.689 . . . . 0.96999999999999997 112.86 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.727 ' O ' HG23 ' A' ' 186' ' ' ILE . 2.9 mp -62.54 -54.35 41.1 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.999 0.74 . . . . 0.71999999999999997 112.999 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.423 ' HA ' HG12 ' A' ' 186' ' ' ILE . 4.1 t60 -41.67 -39.03 1.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.826 0.346 . . . . 1.5900000000000001 111.613 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -44.27 76.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.516 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -70.85 -37.71 73.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.051 -0.522 . . . . 0.59999999999999998 110.696 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 182' ' ' LEU . 1.2 pt -74.03 -49.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.449 -0.341 . . . . 0.46999999999999997 111.858 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.452 ' N ' ' CG1' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -63.26 -47.49 82.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 2.73 110.535 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.12 -30.4 68.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 2.21 110.841 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -111.1 52.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 2.46 111.065 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.4 -89.34 0.82 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.697 -0.763 . . . . 1.79 112.592 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.41 -162.19 30.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.862 -0.685 . . . . 0.57999999999999996 112.356 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.702 ' CD1' HD12 ' A' ' 186' ' ' ILE . 24.9 m0 -59.11 -37.56 77.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.60999999999999999 110.911 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 196' ' ' VAL . 12.3 p-10 -69.05 -25.88 64.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 2.0800000000000001 111.508 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.55 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.34000000000000002 110.951 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.532 ' CZ ' HG22 ' A' ' 93' ' ' THR . 2.1 t80 -69.66 -41.61 75.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 1.1799999999999999 111.777 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -63.15 -32.65 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.635 -0.426 . . . . 1.02 110.768 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -68.64 -41.04 79.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.005 0.431 . . . . 2.0600000000000001 109.845 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.06 -44.52 72.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.851 -0.613 . . . . 1.3100000000000001 110.154 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.639 ' CD1' H402 ' A' 1000 ' ' LIU . 47.4 m-85 -107.07 53.88 0.68 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.872 0.844 . . . . 1.76 110.873 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.48 110.32 3.13 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 113.724 -1.58 . . . . 1.8999999999999999 110.395 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.22 158.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.281 1.988 . . . . 2.8700000000000001 112.725 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 60.5 p -47.14 98.81 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.066 -0.515 . . . . 5.0899999999999999 110.205 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 83.27 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.523 -0.762 . . . . 6.1900000000000004 112.065 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.259 -0.877 . . . . 7.6299999999999999 110.865 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' LIU . . . . . 0.892 ' H33' HG11 ' A' ' 145' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_